The role of chemoinformatics in the design of a comprehensive drug ...
The role of chemoinformatics in the design of a comprehensive drug ...
The role of chemoinformatics in the design of a comprehensive drug ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Databases <strong>of</strong> Known Pharmaceutical Ligands and Drugs<br />
Structure<br />
MDDR-3D 2001.1<br />
(23.01)<br />
Extreg 185987<br />
Pref#<br />
Preview<br />
Phase<br />
185987<br />
Act.<strong>in</strong>vest<br />
Launched<br />
Index Activity<br />
28000 Cardiotonic<br />
31000 Antihypertensive<br />
31432 Angiotens<strong>in</strong> II<br />
AT1 Antagonist<br />
Model<br />
Structure<br />
O<br />
Identification<br />
O<br />
N<br />
O<br />
Biology<br />
N<br />
N<br />
Lit & Patent<br />
Chiral<br />
N<br />
N<br />
Source<br />
Novartis<br />
Company.code<br />
CGP-48933<br />
CGP-63170 (comb. with<br />
Generic name<br />
Valsartan < Rec INN; USAN ><br />
Trademark<br />
Valpression (Menar<strong>in</strong>i, IT)<br />
Provas (Schwarz, DE)<br />
Varexan (Egis, HU)<br />
Di (N ti CA DE<br />
| Obernai| 20.06.10 | Edgar Jacoby
Change language